In the present study, the administration of NGF significantly exacerbated airway eosinophilic inflammation, increased the total inflammatory cell number and the production of IL-13 and IL-4 in the BALF, as well as goblet cell hyperplasia in the epithelium whereas treatment with anti-NGF clearly reduced these factors. This evidence concerns the gene IL13 and inflammatory response.